NHSBSA | August 2021 | Prescribing for Diabetes – England 2015/16 to 2020/21
This publication from the NHS Business Services Authority aims to describe the prescribing of medicines and appliances used for the treatment of diabetes in a primary care setting in England that are dispensed in the community
- in 2020/21, there were 57.9 million drugs used in treating diabetes prescribed in England for a cost of £1.19 billion, 12.5% of the total spend on all prescription items prescribed in England. This was an increase from 2015/16 where 49.7 million diabetes items were prescribed in England for a cost of £958 million, representing 10.4% of the total spend on all prescriptions items.
- antidiabetic drugs were the most prescribed drugs used in treating diabetes in England in 2020/21 with 43.1 million items at a cost of £686 million. The costs of antidiabetic drugs have increased by 62% since 2015/16 from £423 million.
- there were 3.05 million identified patients that were prescribed drugs used in diabetes in England in 2020/21. This was a 1.5% increase from 3 million identified patients in 2015/16, and a 12.7% increase from 2.70 million in 2015/16.
- the median age of identified patients for drugs used in diabetes was 64 in 2020/21, this has remained consistent since 2015/16. The most common age group in 2020/21 was 70 to 74, this has increased from 2015/16 where the most common age group was 65 to 69.
- areas of greater deprivation have the highest number of identified patients being prescribed drugs used in treating diabetes in 2020/21, with the number of patients receiving prescribing in the most deprived areas of England being 264% of the least deprived areas
- Prescribing for Diabetes England 2015/16 to 2020/21 – Statistical summary narrative (HTML)
- Further resources are available from NHSBSA